Company / SG&A Expense
Bio Essence Corp SG&A Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$497.8K
FY2025
5-year range
$345.6K / $1.1M
FY2021-FY2025
Trend
-26.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $345,590 to $497,809 over the past 2 years.
Based on SEC 10-K filings.
$497,809 in FY2025 with a 3-year CAGR of -13.3%.
Increased from $345,590 to $497,809 over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -13.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -13.3%, indicating a declining trend.
- In FY2025, sg&a expense decreased 26.4% year-over-year.
- Peak sg&a expense was recorded in FY2021.
- Lowest sg&a expense in the period was in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 9/9 (strong financial health signals)
- Altman Z-Score -11.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $497.8K | -26.4% |
| FY2024 | $676.5K | +95.8% |
| FY2023 | $345.6K | -54.7% |
| FY2022 | $763.1K | -29.1% |
| FY2021 | $1.1M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 29, 2026